Literature DB >> 3146465

A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.

P A Morley, L D Munot.   

Abstract

Sodium fusidate ointment and mupirocin ointment were compared in 354 patients with superficial skin sepsis. The ointments were applied 3-times daily, or once daily when covered by a dressing, and the response assessed after 6 to 8 days. Both preparations proved effective clinically with 86% of patients responding. There was no difference between the two preparations in cases of primary infection (85% to both ointments), including a sub-group with impetigo (sodium fusidate 88% and mupirocin 84%), or secondary infection (sodium fusidate 81% and mupirocin 89%). Sodium fusidate ointment (98%) was significantly better (p less than 0.05) than mupirocin (82%) in patients with other superficial infections. Both ointments were equally effective in cases where Gram-positive, Gram-negative or mixed Gram-positive/Gram-negative bacteria were isolated. Adverse effects were reported in 1.0% of patients using sodium fusidate ointment and in 7.4% of patients using mupirocin ointment. The majority of complaints concerned the greasiness of mupirocin ointment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146465     DOI: 10.1185/03007998809110457

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  9 in total

1.  Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.

Authors:  J Gisby; J Bryant
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.

Authors:  Sander Koning; Lisette W A van Suijlekom-Smit; Jan L Nouwen; Cees M Verduin; Roos M D Bernsen; Arnold P Oranje; Siep Thomas; Johannes C van der Wouden
Journal:  BMJ       Date:  2002-01-26

3.  Modelling of the outcome of non-inferiority trials by integration of historical data.

Authors:  Alberto Russu; Erik van Zwet; Giuseppe De Nicolao; Oscar Della Pasqua
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-21       Impact factor: 2.745

Review 4.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Interventions for impetigo.

Authors:  Sander Koning; Renske van der Sande; Arianne P Verhagen; Lisette W A van Suijlekom-Smit; Andrew D Morris; Christopher C Butler; Marjolein Berger; Johannes C van der Wouden
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

Review 6.  A systematic review and meta-analysis of treatments for impetigo.

Authors:  Ajay George; Greg Rubin
Journal:  Br J Gen Pract       Date:  2003-06       Impact factor: 5.386

Review 7.  Fusidic acid resistance in Staphylococcus aureus.

Authors:  D Dobie; J Gray
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

8.  New therapeutic applications of ozenoxacin in superficial skin infections.

Authors:  Gema García Ron; María Villa Arranz
Journal:  Dermatol Reports       Date:  2021-08-05

9.  Treatment of Impetigo with Antiseptics-Replacing Antibiotics (TIARA) trial: a single blind randomised controlled trial in school health clinics within socioeconomically disadvantaged communities in New Zealand.

Authors:  Emma Best; Alison Leversha; Sarah Primhak; Alicia Gataua; Diana Purvis; John M D Thompson; Cameron Walker
Journal:  Trials       Date:  2022-02-02       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.